FDA Approves Glofitamab-gxbm for Relapsed/Refractory DLBCL | OncLive
FDA Approves Glofitamab-gxbm for Relapsed/Refractory DLBCL | Onc…
Jun 16, 2023
onclive.com
Patients with relapsed or refractory diffuse large B-cell lymphoma have a poor prognosis. Glofitamab, a novel T-cell–engaging bispecific antibody, might improve outcomes in these patients. New research findings are summarized in a short video. https://nej.md/3UGxXF7 | The New England Journal of Medicine
2:04
Patients with relapsed or refractory diffuse large B-cell lymphoma hav…
2.1K viewsDec 14, 2022
FacebookThe New England Journal of Medicine
Roche presents new data demonstrating the potential benefit of glofitamab and Lunsumio as fixed-duration, off-the-shelf treatment options for lymphoma
Roche presents new data demonstrating the potential benefi…
Dec 12, 2022
marketscreener.com
Dr Carlo-Stella on the FDA Approval of Glofitamab in Relapsed/Refractory DLBCL | OncLive
Dr Carlo-Stella on the FDA Approval of Glofitamab in Relapsed/Refract…
Jun 16, 2023
onclive.com
Dr. Topp on the Safety Profile of Glofitamab Plus R-CHOP in DLBCL
Dr. Topp on the Safety Profile of Glofitamab Plus R-CHOP in DLBCL
Jan 12, 2023
onclive.com
Practice Patterns and Real Use of Epcoritamab and Glofitamab | OncLive
Practice Patterns and Real Use of Epcoritamab and Glofitamab | Onc…
Aug 19, 2024
onclive.com
Dr Abramson on Findings with Glofitamab, Gemcitabine and Oxaliplatin in R/R DLBCL | OncLive
Dr Abramson on Findings with Glofitamab, Gemcitabine and Oxal…
9 months ago
onclive.com
ASH 2024 Insights: Safety and Efficacy of Glofitamab RICE in R/…
32 viewsJan 21, 2025
vumedi.com
7:21
Linfoma diffuso a grandi cellule B ricaduto/refrattario, via libera Aifa …
615 viewsApr 16, 2024
YouTubePharmaStarTV
Linfoma diffuso a grandi cellule B, via libera Aifa a un nuovo farmaco
Apr 11, 2024
Il Sole 24 ORE
5:07
Glofit-GemOx shows clinically meaningful benefit in relapsed/refr…
140 viewsSep 20, 2024
YouTubeecancer
2:21
Important practical considerations for the use of glofitamab for DLBCL
198 viewsNov 1, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:06
Approaching the treatment of a patient with DLBCL who has relap…
66 views7 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:24
The efficacy of glofitamab in patients with heavily pre-treated R…
227 views4 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:07
Linfoma diffuso a grandi cellule B, via libera Aifa a un nuovo farmaco
54 viewsApr 11, 2024
YouTubeIl Sole 24 ORE
1:15
The benefits of glofitamab in R/R DLBCL post-CAR-T therapy
873 viewsJul 28, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:08
The CRS-RS.5p predictive model of CRS after glofitamab treatment in …
18 views2 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:57
COLUMVI (glofitamab-gxbm)- relapsed or refractory diffuse larg…
425 viewsAug 11, 2024
YouTubePharmacy Talk USA
2:02
Extended follow-up of glofitamab with polatuzumab in heavily pre-tr…
152 viewsDec 10, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
5:46
Glofitamab and polatuzumab vedotin in DLBCL
808 viewsFeb 2, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
4:46
Glofitamab induces durable complete remissions in patients w…
852 viewsJun 15, 2022
YouTubeecancer
1:29
STARGLO 2-year follow-up: durability of responses in patient…
207 views9 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
6:40
[Glofitamab] 글로피타맙 약물특징과 구조
1 month ago
YouTubeDavid Lauren Research | Oncology in 3 minutes.
46:48
Relapsed and Refractory Diffuse Large B-Cell Lymphoma
9.5K viewsFeb 9, 2023
YouTubeLymphoma Research Foundation
5:30
Glofitamab in R/R DLBCL: updated safety and efficacy data
580 viewsOct 21, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
6:00
Glofitamab monotherapy achieves durable responses in R/R DLBCL: …
450 viewsJan 29, 2025
YouTubeVJHemOnc – Video Journal of Hematology & H…
3:17
The BP41072 trial: glofitamab plus englumafusp alfa in patients with …
159 viewsDec 16, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
0:50
NP30179: Glofitamab monotherapy in R/R NHL
122 viewsFeb 2, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:11
Glofitamab and obinutuzumab as first-line therapy for patients with …
97 views3 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:18
Update on Phase I/II study of glofitamab monotherapy in R/R MCL
61 viewsFeb 8, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
See more videos
Static thumbnail place holder